Coronavirus Vaccine Tracker - The New York Times

Coronavirus Vaccine Tracker - The New York Times

Coronavirus vaccine: where we are now

There are more than 135 vaccines in development against the SARS-CoV-2 virus. Only one, from pharmaceutical firm AstraZeneca and the University of Oxford, is starting phase III clinical trials that will test whether it actually works. A pleasantly visual vaccine tracker from The New York Times enumerates the status of all the vaccines that have reached trials in humans, along with a selection of promising vaccines that are being tested in cells or animals.

The New York Times | 6 min read